These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11320823)

  • 1. [Optic neuritis. First manifestation of multiple sclerosis? Current diagnostic and therapeutic strategies].
    Kiefer G; Rieckmann P
    Ophthalmologe; 2001 Mar; 98(3):310-8. PubMed ID: 11320823
    [No Abstract]   [Full Text] [Related]  

  • 2. The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group.
    Beck RW; Trobe JD
    J Neuroophthalmol; 1995 Sep; 15(3):131-5. PubMed ID: 8574355
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What have the optic neuritis treatment trial and the longitudinal optic neuritis study shown us?
    Corbett JJ
    J Neurol Sci; 1994 Aug; 125(1):1-2. PubMed ID: 7964878
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroids and optic neuritis.
    Silberberg DH
    N Engl J Med; 1993 Dec; 329(24):1808-10. PubMed ID: 8232492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk].
    Dtsch Med Wochenschr; 1994 Jun; 119(24):897. PubMed ID: 8005072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multiple evanescent white dot syndrome and multiple sclerosis].
    Querques G; Bux AV; Forte R; Francesco P; Cristiana I; Noci ND
    J Fr Ophtalmol; 2011 Apr; 34(4):252-5. PubMed ID: 21419509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the management of optic neuritis.
    Kortvelesy S
    Hawaii Med J; 1997 Oct; 56(10):281. PubMed ID: 9385746
    [No Abstract]   [Full Text] [Related]  

  • 9. The optic neuritis treatment trial: implications for clinicians.
    Katz B; Trobe JD; Beck RW
    Semin Ophthalmol; 1995 Sep; 10(3):214-20. PubMed ID: 10159746
    [No Abstract]   [Full Text] [Related]  

  • 10. Optic neuritis treatment trial.
    Levi L
    J Neuroophthalmol; 1995 Dec; 15(4):261-2; author reply 262-3. PubMed ID: 8748563
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience of the optic neuritis treatment trial.
    Corbett J
    Curr Neurol Neurosci Rep; 2004 Sep; 4(5):383. PubMed ID: 15324604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulse therapy in the treatment of optic neuritis in multiple sclerosis].
    Neroev VV; Karlova IZ; Guseva MR; Zaĭtseva OV; Boĭko SIu; Sidorenko EI; Dubovskaia LA; Budzinskaia MV; Boĭko AN
    Vestn Oftalmol; 2003; 119(5):28-31. PubMed ID: 14598491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic neuritis and multiple sclerosis: long-term prognostic considerations.
    Kattah JC
    Arch Neurol; 2005 Mar; 62(3):506; author reply 507. PubMed ID: 15767522
    [No Abstract]   [Full Text] [Related]  

  • 14. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 15. The optic neuritis treatment trial: three-year follow-up results.
    Beck RW
    Arch Ophthalmol; 1995 Feb; 113(2):136-7. PubMed ID: 7864737
    [No Abstract]   [Full Text] [Related]  

  • 16. Ophthaproblem. Optic neuritis.
    Blair J; Sharma S
    Can Fam Physician; 2003 Oct; 49():1285, 1289. PubMed ID: 14594095
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of i.v. methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis.
    Kolar OJ; Finley JC
    Neurology; 1998 Nov; 51(5):1516-7. PubMed ID: 9818911
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical update on optic neuritis and multiple sclerosis.
    Murphy MA
    Med Health R I; 2008 Feb; 91(2):57-9. PubMed ID: 18372861
    [No Abstract]   [Full Text] [Related]  

  • 19. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in optic neuritis due to giant cell arteritis.
    Garcia-Porrua C; Santamarina R; Armesto V; Gonzalez-Gay MA
    Arthritis Rheum; 2005 Apr; 53(2):313-4. PubMed ID: 15818643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.